Advanced Psychiatry Associates
Mental health clinic in Walnut Creek, California.
No reviews yet
View DetailsSpravato (Esketamine) in Walnut Creek, California
Compare 4 Spravato (Esketamine) clinics in Walnut Creek, California that offer care for treatment-resistant depression and major depressive disorder. Review services, ratings, and contact details to find the right provider near you.
Clinics
4 clinics shown
BASS Medical Group - Neurology
BASS Medical Group operates a neurology practice in Walnut Creek on Lennon Lane, providing diagnostic and treatment services for neurological conditions. The clinic is part of a multi-specialty medical group with locations across the East Bay region. Specific offerings related to TMS, ketamine, or esketamine treatments are not detailed in available information; patients seeking procedural interventions for treatment-resistant depression should contact the practice directly to confirm whether those services are available through their neurology department.
No reviews yetView DetailsMindful Health Solutions - Walnut Creek
Mindful Health Solutions operates a psychiatry practice in Walnut Creek on Olympic Boulevard, providing outpatient mental health services for adults. The clinic's listing indicates psychiatry as the primary service, though specific treatment modalities such as TMS, esketamine, or ketamine are not detailed in available data. Patients seeking information about procedural treatments for treatment-resistant depression should contact the practice directly to confirm current offerings and insurance acceptance.
No reviews yetView DetailsMindpath Health Psychiatrists & Therapists - Walnut Creek
Mindpath Health operates an outpatient psychiatry and psychotherapy practice in Walnut Creek on North Civic Drive, serving adults and adolescents with mood disorders, anxiety, ADHD, and related conditions. The clinic provides medication management and individual therapy but does not list TMS, ketamine, or esketamine among its available treatments based on current data. Patients seeking procedural interventions for treatment-resistant depression should confirm service availability directly with the practice before scheduling.
4.3(156)View Details
About Spravato (Esketamine)
Spravato is the brand name for esketamine, an FDA-approved nasal spray for treatment-resistant depression and major depressive disorder with suicidal ideation. It's derived from ketamine and works on the brain's glutamate system — a different mechanism than traditional antidepressants like SSRIs.
Treatment is administered only at REMS-certified clinics under direct medical supervision. Patients self-administer the spray under a clinician's guidance, then remain at the clinic for at least two hours of monitoring after each dose. The induction phase typically involves twice-weekly sessions for four weeks, followed by weekly or biweekly maintenance dosing depending on response.
Many patients report meaningful symptom improvement within the first one to two weeks — substantially faster than the 4 to 8 weeks typical of oral antidepressants. Spravato is taken alongside an oral antidepressant, not as a replacement.
The most common side effects are dissociation, dizziness, sedation, and elevated blood pressure during and shortly after dosing. These typically resolve within the two-hour monitoring window. Patients cannot drive on the day of treatment.
Most commercial insurance and Medicare cover Spravato for treatment-resistant depression with prior authorization. Clinics offering Spravato in our directory hold active REMS certification and are staffed to provide the required in-clinic monitoring period.